Is patient assistance program legitimate?
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical manufacturers and are promoted as a safety net for Americans who have no health insurance or are underinsured.
What does Collegium Pharmaceutical do?
We have a portfolio of meaningfully differentiated medications to treat serious medical conditions, including moderate-to-severe pain and acute migraine.
Who bought Bdsi?
CollegiumOn March 22, 2022, Collegium completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium.
How many employees does Collegium Pharmaceutical have?
266 employeesCollegium Pharmaceutical is a medium pharmaceutical company with 266 employees and an annual revenue of $310.0M that is headquartered in Massachusetts.
What drug company makes Xtampza?
See full Important Safety Information and Other Serious Risks at Symproic.com/#isi. Xtampza® ER, BELBUCA®, NUCYNTA® ER, and NUCYNTA® are registered trademarks of Collegium Pharmaceutical, Inc.